Caelum Biosciences Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $500M

Caelum Biosciences General Information

Description

Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditions. The company is engaged in development of antibodies that work to break up pre-existing amyloid in tissues and to help the body's immune system remove the deleterious material, enabling patients with a greater chance to be a safe, receive well-tolerated therapy that promotes amyloid resolution and improve organ responses.

Contact Information

Website
www.caelumbio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Rutgers Ecocomplex
  • 1200 Florence Road
  • Bordentown, NJ 08505
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Alexion
Vertical(s)
Life Sciences
Corporate Office
  • Rutgers Ecocomplex
  • 1200 Florence Road
  • Bordentown, NJ 08505
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Caelum Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 06-Oct-2021 $500M Completed Clinical Trials - Phase 3
1. Early Stage VC 30-Jan-2019 Completed Clinical Trials - Phase 3
To view Caelum Biosciences’s complete valuation and funding history, request access »

Caelum Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a clinical-stage biotechnology comapny intended to develop treatments for rare and life-threatening conditio
Biotechnology
Bordentown, NJ

Redwood City, CA
 

Pasadena, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Caelum Biosciences Competitors (56)

One of Caelum Biosciences’s 56 competitors is Adverum Biotechnologies, a Formerly VC-backed company based in Redwood City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Adverum Biotechnologies Formerly VC-backed Redwood City, CA
Meditope Biosciences Venture Capital-Backed Pasadena, CA
Apeptico Venture Capital-Backed Vienna, Austria
NexImmune Formerly VC-backed Gaithersburg, MD
Glycomine Venture Capital-Backed San Carlos, CA
You’re viewing 5 of 56 competitors. Get the full list »

Caelum Biosciences Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 10

    Pending

  • Expiring in next 12 mo

Caelum Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3231073-A1 Method of treating multiple myeloma Pending 14-Sep-2021
EP-4401839-A2 Method of treating multiple myeloma Pending 14-Sep-2021
AU-2022346750-A1 Method of treating multiple myeloma Pending 14-Sep-2021
US-20240392028-A1 Method of treating multiple myeloma Pending 14-Sep-2021
AU-2021339851-A8 Method of treating amyloidosis Pending 14-Sep-2020 C07K16/18
To view Caelum Biosciences’s complete patent history, request access »

Caelum Biosciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Columbia Technology Ventures University Minority
To view Caelum Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Caelum Biosciences FAQs

  • When was Caelum Biosciences founded?

    Caelum Biosciences was founded in 2015.

  • Where is Caelum Biosciences headquartered?

    Caelum Biosciences is headquartered in Bordentown, NJ.

  • What industry is Caelum Biosciences in?

    Caelum Biosciences’s primary industry is Biotechnology.

  • Is Caelum Biosciences a private or public company?

    Caelum Biosciences is a Private company.

  • What is the current valuation of Caelum Biosciences?

    The current valuation of Caelum Biosciences is .

  • What is Caelum Biosciences’s current revenue?

    The current revenue for Caelum Biosciences is .

  • How much funding has Caelum Biosciences raised over time?

    Caelum Biosciences has raised $69.9M.

  • Who are Caelum Biosciences’s investors?

    Columbia Technology Ventures has invested in Caelum Biosciences.

  • Who are Caelum Biosciences’s competitors?

    Adverum Biotechnologies, Meditope Biosciences, Apeptico, NexImmune, and Glycomine are some of the 56 competitors of Caelum Biosciences.

  • When was Caelum Biosciences acquired?

    Caelum Biosciences was acquired on 06-Oct-2021.

  • Who acquired Caelum Biosciences?

    Caelum Biosciences was acquired by Alexion.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »